Affymetrix and Roche Diagnostics have separately filed for de novo 510(k) approval from the US Food and Drug Administration of their microarray-based diagnostic for drug metabolism, the companies confirmed last week for BioArray News’ sister publication GenomeWeb News.

Affy filed for clearance of its GeneChip 3000Dx reader, while Roche is seeking approval for its CYP450 AmpliChip. Both attained a Conformité Européenne Mark in early September for the microarray — the first product developed under their collaboration inked in Jan. 2003.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

In Science this week: approach to visualize chromatin structure in nuclei, and more.